Short versus long duration infusions of paclitaxel for any adenocarcinoma

Medicine and Dentistry

• Infusion 100%
• Patient 23%
• Side Effect 17%
• Chemotherapeutic Agent 17%
• Drug 17%
• Malignant Neoplasm 17%
• Toxicity 11%
• Meta-Analysis 11%
• Adenocarcinoma 11%
• Randomized Controlled Trial 11%
• Allergic Response 11%
• Female Genital Tract Cancer 5%
• Infection 5%
• Hypersensitivity 5%
• Fever 5%
• Therapeutic Procedure 5%
• Independent Reviewer 5%

Nursing and Health Professions

• Paclitaxel 58%
• Adenocarcinoma 11%
• Cancer Center 5%
• Cancer Localization 5%
• Antiallergic Agent 5%
• Mouth Pain 5%
• Fever 5%
• Female Genital Tract Cancer 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Paclitaxel 58%
• Allergic Reaction 11%
• Female Genital Tract Cancer 5%
• Antiallergic Agent 5%
• Erethism 5%
• Mouth Pain 5%